India — Coffee and Tea

← back to leaderboard

India received 14 FDA import refusals in Coffee and Tea between 2023-Q4 and 2026-Q3. Volume peaked at 4 in 2023-Q4, with the trend falling sharply year-on-year. The most-cited issues are unsafe add, unapproved, and suppl gmp. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 9 were hazard refusals and 5 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

4 2023-Q4 2023-Q4: 4 0 2024-Q1 2024-Q1: 0 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 2 2024-Q4 2024-Q4: 2 1 2025-Q1 2025-Q1: 1 3 2025-Q2 2025-Q2: 3 3 2025-Q3 2025-Q3: 3 0 2025-Q4 2025-Q4: 0 0 2026-Q1 2026-Q1: 0 0 2026-Q2 2026-Q2: 0 1 2026-Q3 2026-Q3: 1

Recent rejections